Combinatory effects of androgen receptor deficiency and hind limb unloading on bone

Hormone and Metabolic Research

Volumn 41, Issue 11, 2009, Pages 822-828

  Salta, Y ^a,b   Nakamura, T ^c   Mizoguchi, F ^a   Nakashlma, K ^a   Hemmi, H ^a   Hayata, T ^a   Ezura, Y ^a   Kurosawa, H ^b   Kato, S ^c   Noda, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANDROGEN RECEPTOR; COLECALCIFEROL; DEOXYPYRIDINOLINE; DEXAMETHASONE;

ANDROGEN RECEPTOR DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DISEASE MODEL; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRABECULAR BONE; URINARY EXCRETION;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HINDLIMB SUSPENSION; HUMANS; MALE; MICE; MICE, KNOCKOUT; OSTEOCLASTS; RECEPTORS, ANDROGEN;

MUS;

EID: 70649104041     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1231056     Document Type: Article

References (26)

1. Vicente-Rodriguez G. How does exercise affect bone development during growth? Sports Med 2006; 36: 561-569
2. Nordstrom A, Karlsson C, Nyquist F, Olsson T, Nordstrom P, Karlsson M. Bone loss and fracture risk after reduced physical activity. J Bone Miner Res 2005; 20: 202-207
3. Takata S, Yasui N. Disuse osteoporosis. J Med Invest 2001; 48:147-156
4. LeBlancA, Schneider V, Shackelford L Bone mineral and lean tissue loss after long duration space flight. J Musculo Neur Interact 2000; 1 : 157-160
5. LeBlanc AD, Schneider VS, Evans HJ, Engelbretson DA, Krebs JM. Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 1990; 5: 843-850
6. Liedert A, Kaspar D, Blakytny R, Claes L, Ignatius A. Signal transduction pathways involved in mechanotransduction in bone cells. Biochem Biophys Res Commun 2006; 349:1-5
7. Looker AC, Orwoll ES, Johnston Jr CC, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12: 1761-1768
8. Orwoll ES. Osteoporosis in men. Endocr Rev 1995; 16: 87-116
9. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69: 523-527 (Pubitemid 19221221)
10. Morote J, Orsola A, Abascal JM, Planas J, Trilla E, Raventos CX, Cecchini L, Encabo G, Reventos J. Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression. J Urol 2006; 175 : 1679-1683
11. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352: 154-164
12. Qpubaitary A, Swerdloff RS, Wang C. Advances in male hormone substitution therapy. Expert Opin Pharmacother 2005; 9:1493-1506
13. Gori F, Hojbauer LC, Conover CA, Khosla S. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology 1999; 140: 5579-5586
14. Jilka RL, Hangoc G, Cirasole G, Passeri G, Williams DC, Abrams JS, Boyce B,Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88-91
15. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 2001 ; 276: 8836-8840
16. Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamtchi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S. Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci U S A 2003; 100: 9416-9421 (Pubitemid 37033943)
17. Lee KC, Lanyon LE. Mechanical loading influences bone mass through estrogen receptor alpha. Exerc Sport Sci Rev 2004; 32: 64-68
18. Lee K, Jessop H, Suswillo R, Zaman G, Lanyon L. Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 2003; 424: 389
19. van den BeId AW, de Jong FH, Crobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85: 3276-3282
20. Snow-Harter C, Whalen R, Myburgh K, Arnaud S, Marcus R. Bone mineral density, muscle strength, and recreational exercise in men. J Bone Miner Res 1992; 11:1291-1296 (Pubitemid 23000969)
21. Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji, Denhardt DT, Noda M. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 2003; 144: 2132-2140 (Pubitemid 36543353)
22. Ahiborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med 2003; 349: 327-334
23. Kannus P, Sievänen H, Palvanen M, Järvinen T, Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet 2005; 366: 1885-1893 (Pubitemid 41690118)
24. Imai Y, Nakamura T, Matsumoto T, Ioue K, Kondoh S, Sato T, Takaoka K, Kato S. Osteoblastic androgen receptor regulates cortical bone mineral density. J Bone Mineral Res 2008; 23: s35
25. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007; 130: 811-823 (Pubitemid 47332572)
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2002-2007